Two further studies reported broad activity of GEM in combination with CHEK1 inhibition in NSCLC cells (Nair et al, 2023), or CHEK1i and WEE1i across several cancer entities other than PDAC (O’Neil et al, 2016). The gene discussed is CHEK1; the disease is cancer.